1. Home
  2. VIVS vs BAOS Comparison

VIVS vs BAOS Comparison

Compare VIVS & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIVS
  • BAOS
  • Stock Information
  • Founded
  • VIVS 2007
  • BAOS 2018
  • Country
  • VIVS United States
  • BAOS China
  • Employees
  • VIVS N/A
  • BAOS N/A
  • Industry
  • VIVS Biotechnology: Biological Products (No Diagnostic Substances)
  • BAOS Business Services
  • Sector
  • VIVS Health Care
  • BAOS Consumer Discretionary
  • Exchange
  • VIVS Nasdaq
  • BAOS Nasdaq
  • Market Cap
  • VIVS 5.0M
  • BAOS 4.2M
  • IPO Year
  • VIVS N/A
  • BAOS 2021
  • Fundamental
  • Price
  • VIVS $2.21
  • BAOS $3.00
  • Analyst Decision
  • VIVS
  • BAOS
  • Analyst Count
  • VIVS 0
  • BAOS 0
  • Target Price
  • VIVS N/A
  • BAOS N/A
  • AVG Volume (30 Days)
  • VIVS 70.9K
  • BAOS 57.5K
  • Earning Date
  • VIVS 08-05-2025
  • BAOS 08-05-2025
  • Dividend Yield
  • VIVS N/A
  • BAOS N/A
  • EPS Growth
  • VIVS N/A
  • BAOS N/A
  • EPS
  • VIVS N/A
  • BAOS N/A
  • Revenue
  • VIVS $144,000.00
  • BAOS $624,087.00
  • Revenue This Year
  • VIVS $42.38
  • BAOS N/A
  • Revenue Next Year
  • VIVS $15.42
  • BAOS N/A
  • P/E Ratio
  • VIVS N/A
  • BAOS N/A
  • Revenue Growth
  • VIVS 32.11
  • BAOS N/A
  • 52 Week Low
  • VIVS $1.41
  • BAOS $1.44
  • 52 Week High
  • VIVS $21.96
  • BAOS $13.66
  • Technical
  • Relative Strength Index (RSI)
  • VIVS N/A
  • BAOS 55.58
  • Support Level
  • VIVS N/A
  • BAOS $2.76
  • Resistance Level
  • VIVS N/A
  • BAOS $3.22
  • Average True Range (ATR)
  • VIVS 0.00
  • BAOS 0.22
  • MACD
  • VIVS 0.00
  • BAOS 0.03
  • Stochastic Oscillator
  • VIVS 0.00
  • BAOS 69.44

About VIVS VivoSim Labs Inc. Common Stock

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.

Share on Social Networks: